First-Line Treatment for Anxiety
The first-line treatment for anxiety disorders should be either selective serotonin reuptake inhibitors (SSRIs) or cognitive behavioral therapy (CBT), with combination therapy (SSRI plus CBT) offering superior outcomes for more severe cases. 1
Pharmacological First-Line Options
SSRIs
- SSRIs are recommended as first-line pharmacotherapy for anxiety disorders due to their established efficacy and favorable side effect profile 2, 1
- Specific SSRIs with strong evidence include:
- When initiating SSRI treatment:
- Start with a low dose and gradually increase as tolerated 2
- Consider beginning with a subtherapeutic "test" dose as SSRIs can initially increase anxiety 2
- Titrate dose at 1-2 week intervals for shorter half-life SSRIs (sertraline, citalopram) 2
- Titrate dose at 3-4 week intervals for longer half-life SSRIs (fluoxetine) 2
SNRIs
- SNRIs like venlafaxine are also effective first-line pharmacological options 2, 4
- Duloxetine is the only SNRI with FDA indication for generalized anxiety disorder in children and adolescents 7 years and older 2
- SNRIs may cause side effects including fatigue/somnolence, diaphoresis, dry mouth, and gastrointestinal symptoms 2
Psychological First-Line Options
Cognitive Behavioral Therapy (CBT)
- CBT is a first-line psychological treatment with strong evidence of efficacy 2, 1, 4
- Recommended structure: approximately 14 sessions over 4 months, with each session lasting 60-90 minutes 2, 1
- Key components include:
- For patients who don't want face-to-face CBT, self-help with support based on CBT principles is suggested 2
Combination Treatment
- The combination of CBT and an SSRI is superior to either treatment alone, particularly for moderate to severe anxiety 2, 1
- This combination approach improves primary anxiety symptoms, global functioning, treatment response, and remission rates 2
- Consider combination therapy as the preferred approach for patients with social anxiety, generalized anxiety, separation anxiety, or panic disorder 2
Treatment Algorithm
- Assess severity and type of anxiety disorder 1
- For mild to moderate anxiety:
- For moderate to severe anxiety:
- If initial SSRI is ineffective or poorly tolerated:
- For maintenance:
- Continue medication for 6-12 months after remission to prevent relapse 5
Important Considerations
- Benzodiazepines are not recommended for routine use due to dependence potential 5
- Monitor for adverse effects of SSRIs/SNRIs, particularly in the first 24-48 hours after dosage changes 2
- Anxiety disorders are often chronic and may require long-term treatment 6
- Remission is attainable but can take several months, and stopping medication increases relapse risk within the first year 6